3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Anemia
7
Colorectal Neoplasms
4
Anemia, Iron-Deficiency
4
Postoperative Complications
3
Neoplasms
3
Adenocarcinoma
2
Uterine Cervical Neoplasms
1
Stomach Neoplasms
1
Plexosarcoma
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Liver Neoplasms
1
Inflammatory Breast Neoplasms
1
Gastrointestinal Stromal Tumors
1
Endometrial Neoplasms
1
Colonic Neoplasms
1
Carcinoma, Ductal, Breast
1
Cancer Anaemia
1
Aortic Aneurysm
1
Advanced Gastric Carcinoma
1
Interventions
Sorafenib
42
Bevacizumab
26
Oxaliplatin
21
Radiosurgery
19
Gemcitabine
17
Fluorouracil
15
Hepatectomy
13
lenvatinib
12
Radiofrequency Ablation
11
Nivolumab
11
Cisplatin
11
Radiotherapy
10
Doxorubicin
10
Capecitabine
10
durvalumab
9
Leucovorin
9
Blood Specimen Collection
9
atezolizumab
8
Liver Transplantation
8
Everolimus
7
Electroporation
7
pembrolizumab
6
camrelizumab
6
Sunitinib
6
Immunohistochemistry
6
Cryosurgery
6
Carboplatin
6
tremelimumab
5
sintilimab
5
apatinib
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Liver Neoplasms
×
ferric carboxymaltose
×
Clear all
NCT05744219
2024-10-21
IRIS
Uppsala University Hospital
Phase 3
Recruiting
338 enrolled